16430 studies found for:    "Respiratory Tract Diseases"
Show Display Options
Rank Status Study
1 Completed Botswana Pediatric Respiratory Disease and Bloodstream Infection Study
Conditions: HIV Infections;   Respiratory Tract Diseases;   Sepsis
Intervention: Procedure: blood draws, etc.
2 Not yet recruiting Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease
Conditions: Chronic Rhinosinusitis;   Aspirin Exacerbated Respiratory Disease;   Asthma;   Aspirin Sensitivity
Intervention: Behavioral: Low salicylate diet
3 Completed A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only
Conditions: Aspirin-exacerbated Respiratory Disease;   Nasal Polyp
Intervention: Genetic: microRNA
4 Recruiting What is an Important Change in the Short Physical Performance Battery (SPPB)?
Conditions: Respiratory Tract Diseases;   Lung Diseases
Intervention: Other: Pulmonary rehabilitation
5 Unknown  Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease
Intervention:
6 Active, not recruiting Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease (AERD)
Interventions: Drug: Ifetroban, Oral Capsule;   Drug: Placebo, Oral Capsule
7 Completed Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma
Conditions: Respiratory Tract Diseases;   Respiratory Hypersensitivity;   Asthma
Intervention: Drug: ciclesonide (XRP1526)
8 Active, not recruiting Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Low dose of H5 VLP vaccine + Alhydrogel;   Biological: Med dose of H5 VLP vaccine + Alhydrogel;   Biological: High dose of H5 VLP vaccine + Alhydrogel;   Biological: Low dose of H5 VLP vaccine + GLA-SE;   Biological: High dose of H5 VLP vaccine + GLA-SE;   Biological: Placebo comparator: Placebo
9 Not yet recruiting Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Low dose of H7 VLP vaccine + Alhydrogel;   Biological: Med dose of H7 VLP vaccine + Alhydrogel;   Biological: High dose of H7 VLP vaccine + Alhydrogel;   Biological: High dose of H7 VLP vaccine;   Biological: Placebo
10 Completed
Has Results
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
Condition: Respiratory Tract Diseases
Interventions: Biological: DR-5001;   Other: Placebo
11 Not yet recruiting Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion
Condition: Respiratory Tract Diseases
Intervention: Procedure: Ex vivo lung transplantation
12 Completed Cardiopulmonary Effects of Particulate Exposure
Conditions: Respiratory Tract Diseases;   Cardiac Diseases;   Bronchitis
Intervention:
13 Unknown  Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
Conditions: Pulmonary Disease, Chronic Obstructive;   Respiratory Tract Diseases;   Lung Diseases;   Lung Diseases, Obstructive;   Bronchitis, Chronic;   Pulmonary Emphysema;   Disease Progression
Intervention:
14 Withdrawn A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
Conditions: Asthma, Bronchial;   Lung Diseases, Obstructive;   Respiratory Tract Diseases;   Bronchial Diseases
Interventions: Drug: PF-00610355;   Drug: PF - 00610355;   Other: Placebo
15 Active, not recruiting DNA-based Influenza Vaccine in the Elderly
Conditions: Influenza, Human;   Orthomyxoviridae Infections;   RNA Virus Infections;   Virus Diseases;   Respiratory Tract Infections;   Respiratory Tract Diseases
Intervention: Biological: FVH1 - a DNA-based influenza vaccine
16 Completed Lymphocytes Cut Off Values of Induced Sputum Samples in Healthy and Non-healthy Patients- A Cross Sectional Study
Conditions: Respiratory Tract Diseases;   Occupational Diseases;   Disorders of Environmental Origin
Intervention:
17 Completed Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases
Condition: Respiratory Tract Diseases
Intervention:
18 Unknown  Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU)
Conditions: Nervous System Diseases;   Respiratory Tract Diseases;   Cardiovascular Diseases;   Immune System Diseases
Intervention: Drug: Oxygen
19 Recruiting Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Conditions: Pancreatic Insufficiency;   Cystic Fibrosis;   Digestive System Diseases;   Lung Diseases;   Respiratory Tract Diseases
Interventions: Drug: Burlulipase;   Drug: Placebo (Caramel in sterile water)
20 Completed Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: H5 VLP pandemic influenza vaccine 5 µg;   Biological: H5 VLP pandemic influenza vaccine 10 µg;   Biological: H5 VLP pandemic influenza vaccine 20 µg;   Biological: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years